Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sorafenib...a Jitterbug amongst Iphone 11's. LOL
Yep, a real flip phone. Still dials and places calls but nobody uses them anymore because there's so many better alternatives. Bayer better be buying AVEO if you're a Bayer guy Harry. LMAO.
Nobody selling. NOBODY. Surely the tutes and NEA would be in full liquidation mode if AVEO was as you say it is. What's it like being the biggest liar online?
ROFLMAO! Can't wait to watch you eat your crow dinner in 2020. Is Bayer the buyout company Harry? Makes the most sense.
Sorafenib is the flip phone of RCC treatment. Fact. LOL
They'll be plenty of people on AVEO once the NDA is filed. Plenty.
I get it just fine. The FDA can't fast track a drug that has yet to have an NDA submitted. Your peculiar infatuation with this company's demise by way of slandering and posting libelous rants about it is uncanny and speaks volumes about your integrity as a human.
https://www.eurekalert.org/multimedia/pub/218779.php
They've already met with the FDA and agreed that AVEO would submit the NDA in Q1 followed by the final hazard ratio readout of T3 data in June, with a <1 reading being the hinge pin on that readout as to whether the NDA moves forward or is withdrawn. It's very peculiar how some here lie on every post they make.
The Hazard ratio was below 1 at interim readout in August and continues to decrease as Tivo patients have outlived all control patients.
When least expected.
Well, with 20 patients still alive on Tivo and only 2 still alive on Sora, whatever you call "not superior" is likely a mystery to most.
Sora is the flip phone of RCC drugs. It's hardly used anymore in Europe.
Highly unlikely this time around, especially with the growing success in Europe. Tivo is superior to Sora and the comparison is like comparing a flip phone to an I-Phone
No clue? Right, like your "boatload of short shares at .65," right?
If that's the case, why can't army break that wall? A bunch of inept liars is nothing more than a bunch of inept liars. LOL.
$57,000,000 cash on hand = .36/share strictly based on liquid cash. How does AVEO get to .10 again Harry?
Not the postings of a company on the verge of failure:
https://www.google.com/search?ibp=htl;jobs&hl=en-US&kgs=184efeda2e7e5534&q=aveo+linkedin+positions+2019&shndl=-1&source=sh/x/im/textlists/detail&entrypoint=sh/x/im/textlists/detail#fpstate=tldetail&htidocid=8xsKk_LYD8qUlvDKAAAAAA%3D%3D&htiq=aveo+linkedin+positions+2019&htivrt=jobs
More of your nonsense refuted: https://link.springer.com/article/10.1007/s12325-019-01167-2
Yes, CEO's always BUY stock right before a company's stock is halted. Furthermore, how is it that there's not 1 insider share of stock that's been sold in forever? Do you EVER reflect on the garbage you post on the internet?
They're more likely to be filing the NDA earlier than previously stated for Q1 2020. You know, like they did with the data update in Sept vs. Q4. Shorts will need fireproof underware
Nope. The shorts are done until the next phase. Learn to trade. You're boatload short trade at .65 was a bust. No money to be had there. Or were you lying again?
Shorts did crushed it. Past tense. Longs crushed it 2 years ago. Stocks go up and stocks go down. It's the longs' time again.
AVEO will crush the cockroaches in due time.
https://www.eurekalert.org/multimedia/pub/218779.php
Until today. This is a trader's dream between .65 and .75 until the NDA filing. Or is the FOMO too much?
Higher highs and higher lows EVERY DAY since Nov 25
Stage 4 RCC. 44 months of PFS on Tivo. Is this a scam drug?
New December slide deck out. Look out sorafinib!
https://investor.aveooncology.com/static-files/fa911268-0a62-4a85-a22c-113346ab4fa4
The sheer number of falsehoods posted about this company on this message board by ONE individual is astounding.
7th day in a row of higher highs and higher lows. Pretty shoddy work by the short degenerates amongst us.
It's already been re-assessed this year and green lighted until the next customary new drug re-assessment in 2020. Get with the program. https://www.ema.europa.eu/en/medicines/human/EPAR/fotivda
It's been approved for front line treatment across Europe for 2 years.
You gave up some cash on that call Kallie
"Quality of life" Harry. Do you even know what that means?
Harry, this Bud's for you from Dr. Pal: "Tivozanib is an agent that I think is ideally placed, consistent with the recent press release from AVEO, in the refractory setting in patients with advanced renal cell carcinoma. There are perhaps more potent and active agents to use in the front-line setting such as cabozantinib and either alone or in combination with immunotherapeutic agents on the basis of ongoing studies. I will say that tivozanib, however, based on its toxicity profile, represents a very reasonable option to use in the context of patients with more advanced disease. This is a point in time in which patients may potentially prioritize quality of life."
You said you shorted "a boatload" at .65
Why do you want to lose 52% of your money? You can't have it both ways Harry
I get it Harry, Baker Bros got burnt by AVEO's 2013 CRO. Maybe it's time for them to get back on the horse.
The CEO just spent $90K buying into his own scam.
You're impressed by the longs stamina, aren't you Harry>